Vaccination Barriers in Mexico

Immunization is a simple, effective, and low-cost way to protect the child population against infectious diseases. However, various barriers interrupt compliance with the necessary vaccination schedule. For example, anti-vaccine groups that encourage fear and misinform—in this scenario, social networks are an unreliable source of information with high diffusion. Health personnel must help generate trust in patients, provide truthful information and reduce vaccination hesitancy among the population. The main objective of the universal vaccination program is to obtain the greatest possible coverage of vaccines in the entire population, so as to prevent the development of certain pathologies

Epidemiology of SARS-CoV-2 Infection in Mexico and Latin America

This chapter presents some insights into COVID-19 in children. We begin by summarizing the fundamental aspects of SARS-CoV-2 and COVID-19. We also cover issues about the severity of the disease and fatality and factors associated with the outcome of pediatric patients with COVID-19. Most evidence treated in this chapter comes from reports in Mexico, but a general landscape in Latin America is pictured. COVID-19 does not seem to be so severe among children. It is worth noting that those at higher risk are the children between 0 and 2 years who develop pneumonia. In this chapter, we did not discuss extensively the Multisystem Inflammatory Syndrome nor the social impact that the COVID-19 pandemic has had on children. Many studies used for this chapter relied on open data sources resulting from a surveillance system designed for the general population. Therefore, specific variables for children were not analyzed

Post-COVID-19 Condition and Its Presence in Mexico

In this chapter, we discuss general information about the post-COVID-19 condition, also known as long COVID. Since it is still under research, many questions remain unanswered. Nevertheless, post-acute complications due to infections have been previously reported for other viruses. Among those complications that remain are anosmia, fatigue, cardiovascular, and pulmonary. The evidence so far suggests that these complications decrease with time. The most worrying persistent symptoms due to COVID-19 are related to neurological damage. Most post-COVID-19 complications can be treated in a standard way, but their impact on life quality is unknown. Finally, we present a rough landscape of long COVID-19 in Mexico and Latin America. More studies are needed to study this condition and its impact on public health